HE Zhonghui, PAN Yujun, JIANG Hongquan. Vascular Parkinsonism: A Case Report and Literature Review[J]. Chinese Journal of Stroke, 2022, 17(04): 351-353.
[1] KORCZYN A D. Va s cul a r p a rk i nson i smcharacteristics，pathogenesis and treatment[J]. Nat Rev Neurol，11（6）：319-326.
[2] 中华医学会神经病学分会帕金森病及运动障碍学组，中国医师协会神经内科医师分会帕金森病及运动障碍专业委员会. 中国血管性帕金森综合征诊断与治疗专家共识[J]. 中华神经科杂志，2017，50（5）：326-331.
[3] ZIJLMANS J C，DANIEL S E，HUGHES A J，et al. Clinicopathological investigation of vascular parkinsonism，including clinical cr iter ia for diagnosis[J]. Mov Disord，2004，19（6）：630-640.
[4] REKTOR I，BOHNEN N I，KORCZYN A D，et al. An updated diagnostic approach to subtype definition of vascular parkinsonism-recommendations from an expert working group[J/OL]. Parkinsonism Relat Disord，2018，49：9-16[2021-12-10]. https://doi.org/10.1016/j.parkreldis.2017.12.030.
[5] REKTOR I，BOHNEN N I，KORCZYN A D.Subtype definition of vascular parkinsonism[J/OL]. Parkinsonism Relat Disord，2018，52：107-108[2021-12-10]. https://doi.org/10.1016/j.parkreldis.2018.03.005.
[6] LING M J，AGGARWAL A，MORRIS J G L. Doparesponsive parkinsonism secondary to right temporal lobe haemorrahage[J]. Mov Disord，2002，17（2）：402-404.
[7] MURROW R W，SCHWEIGER G D，KEPES J J，et al. Parkinsonism due to a basal ganglia lacunar state： clinicopathologic correlation[J]. Neurology，1990，40（6）：897-900.
[8] ZOU J，CHEN Z G，LIANG C Q，et al. Trefoil factor 3，cholinesterase and homocysteine：potential predictors for Parkinson's disease dementia and vascular parkinsonism dementia in advanced stage[J].Aging Dis，2018，9（1）：51-65.
